BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• BioForest

  PCMA Launches New Campaign: ‘Protect the Savings’ for Medicare Beneficiaries, Taxpayers

  Campaign Highlights How HHS Proposed Rule Will Increase Premiums 25%, Taxpayer Costs Nearly $200 Billion

  February 25, 2019

   · 

  2 min read
• Job Trends

  Paragon 28® launches first-of-its-kind in soft tissue fixation for the foot and ankle - TenoTac™ Soft Tissue Fixation System

  Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery.

  February 25, 2019

   · 

  2 min read
• Business

  Treace Medical Announces Completion of Debt Financing

  Treace Medical Concepts, Inc. announced the completion of a $20 million secured debt financing with Silicon Valley Bank, the bank of the world’s most innovative companies and their investors.

  February 25, 2019

   · 

  2 min read
• Life-saving Better Stop Suicide App Launched Globally Across the Android and Apple App Stores

  A life-saving app, Better Stop Suicide, created by a team of leading psychologists and digital health experts, has been launched globally

  February 25, 2019

   · 

  1 min read
• Business

  Insulet Reports Fourth Quarter 2018 Revenue of $164.9 Million, Up 26% Year-Over-Year, and Full Year 2018 Revenue of $563.8 Million, Up 22%

  Insulet Corporation announced financial results for the three months and full year ended December 31, 2018.

  February 25, 2019

   · 

  11 min read
• Business

  Endologix Reports Fourth Quarter and Fiscal Year 2018 Financial Results

  Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced financial results for the fourth quarter and fiscal year ended December 31, 2018.

  February 25, 2019

   · 

  15 min read
• Policy

  FDA responds to safety signal reported in required postmarketing trial for Xeljanz

  Today the FDA is warning about a safety signal that emerged in a required postmarketing trial of the drug Xeljanz in patients with rheumatoid arthritis.

  February 25, 2019

   · 

  4 min read
• Business

  Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019

  Global Cord Blood Corporation announced its unaudited financial results for the third quarter and first nine months of fiscal year 2019 ended December 31, 2018.

  February 25, 2019

   · 

  22 min read
• Drug Development

  Sesen Bio to Host Conference Call to Review Fourth Quarter and Full-Year 2018 Financial Results and Additional Preliminary Data from Phase 3 VISTA Trial

  Sesen Bio announced that Company management will host a conference call and webcast on Monday, March 4, 2019 at 8:00 a.m. EST

  February 25, 2019

   · 

  1 min read
• Business

  Halo Labs Signs Bulk Biomass Procurement and Bulk Extract Supply Agreement with Cannus Partners in California

  Kiran Sidhu, CEO of Halo Labs said, “We are delighted to partner with Cannus Partners, a vertically integrated cannabis company.

  February 25, 2019

   · 

  5 min read